Harvard Bioscience, Inc. (HBIO): Price and Financial Metrics

Harvard Bioscience, Inc. (HBIO): $4.21

0.10 (+2.43%)

POWR Rating

Component Grades








HBIO Price/Volume Stats

Current price $4.21 52-week high $6.29
Prev. close $4.11 52-week low $1.98
Day low $4.03 Volume 98,490
Day high $4.24 Avg. volume 186,589
50-day MA $4.42 Dividend yield N/A
200-day MA $4.22 Market Cap 179.72M

HBIO Stock Price Chart Interactive Chart >


  • HBIO scores best on the Growth dimension, with a Growth rank ahead of 98.84% of US stocks.
  • HBIO's strongest trending metric is Growth; it's been moving up over the last 177 days.
  • HBIO ranks lowest in Momentum; there it ranks in the 23rd percentile.

HBIO Stock Summary

  • With a year-over-year growth in debt of -14.53%, HARVARD BIOSCIENCE INC's debt growth rate surpasses just 20.38% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, HARVARD BIOSCIENCE INC is reporting a growth rate of 277.79%; that's higher than 94.98% of US stocks.
  • The volatility of HARVARD BIOSCIENCE INC's share price is greater than that of 83.21% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to HARVARD BIOSCIENCE INC, a group of peers worth examining would be TRIP, ECOR, SNES, CAMP, and TALK.
  • Visit HBIO's SEC page to see the company's official filings. To visit the company's web site, go to www.harvardbioscience.com.

HBIO Valuation Summary

  • HBIO's price/sales ratio is 1.5; this is 62.5% lower than that of the median Healthcare stock.
  • HBIO's EV/EBIT ratio has moved down 185.5 over the prior 243 months.

Below are key valuation metrics over time for HBIO.

Stock Date P/S P/B P/E EV/EBIT
HBIO 2023-09-22 1.5 2.3 -32.2 -75.1
HBIO 2023-09-21 1.5 2.3 -32.4 -75.6
HBIO 2023-09-20 1.5 2.3 -32.2 -75.2
HBIO 2023-09-19 1.6 2.4 -33.3 -77.3
HBIO 2023-09-18 1.6 2.5 -34.1 -78.8
HBIO 2023-09-15 1.7 2.6 -35.8 -81.8

HBIO Growth Metrics

    The 5 year net cashflow from operations growth rate now stands at 61.96%.
  • The 2 year net cashflow from operations growth rate now stands at -119.77%.
  • The 3 year net income to common stockholders growth rate now stands at -429.23%.
Over the past 49 months, HBIO's revenue has gone up $3,584,000.

The table below shows HBIO's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 117.963 -1.41 -6.889
2022-06-30 120.704 -2.719 -3.654
2022-03-31 120.693 -1.761 -6.499
2021-12-31 118.904 1.262 -0.288
2021-09-30 116.833 3.635 -1.864
2021-06-30 111.207 5.892 -2.792

HBIO's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • HBIO has a Quality Grade of C, ranking ahead of 42.11% of graded US stocks.
  • HBIO's asset turnover comes in at 0.728 -- ranking 27th of 75 Measuring and Control Equipment stocks.
  • CAMT, NVMI, and ITRI are the stocks whose asset turnover ratios are most correlated with HBIO.

The table below shows HBIO's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.728 0.566 -0.002
2021-03-31 0.693 0.574 0.005
2020-12-31 0.666 0.568 -0.027
2020-12-31 0.666 0.568 -0.027
2020-09-30 0.657 0.564 -0.018
2020-06-30 0.665 0.560 -0.029

HBIO Price Target

For more insight on analysts targets of HBIO, see our HBIO price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $10.00 Average Broker Recommendation 1.38 (Strong Buy)

Harvard Bioscience, Inc. (HBIO) Company Bio

Harvard Bioscience, Inc. develops, manufactures, and markets scientific instruments, systems, and lab consumables used in life science research. The company was founded in 1901 and is based in Holliston, Massachusetts.

HBIO Latest News Stream

Event/Time News Detail
Loading, please wait...

HBIO Latest Social Stream

Loading social stream, please wait...

View Full HBIO Social Stream

Latest HBIO News From Around the Web

Below are the latest news stories about HARVARD BIOSCIENCE INC that investors may wish to consider to help them evaluate HBIO as an investment opportunity.

Harvard Bioscience and Etisense Announce Agreement for Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

Includes dedicated version for integration with Ponemah data management software from Data Sciences International (DSI) Expands reach of unique, non-invasive wearable monitoring for pre-clinical research across North American and European markets HOLLISTON, Mass. and LYON, France, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) and Etisense announced today that they have entered into an agreement to offer DECRO®, Etisense’s non-invasive telemetry jacket and associated

Yahoo | September 18, 2023

Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Could Be 36% Below Their Intrinsic Value Estimate

Key Insights The projected fair value for Harvard Bioscience is US$6.54 based on 2 Stage Free Cash Flow to Equity...

Yahoo | September 10, 2023

Harvard Bioscience President Acquires 1.6% More Stock

Potential Harvard Bioscience, Inc. ( NASDAQ:HBIO ) shareholders may wish to note that the President, James Green...

Yahoo | August 24, 2023

Sidoti Events, LLC’s Virtual August Micro-Cap Conference

Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day August Micro-Cap Conference taking place Wednesday and Thursday, August 16-17, 2023. The presentation schedule is subject to change.

Yahoo | August 15, 2023

Q2 2023 Harvard Bioscience Inc Earnings Call

Q2 2023 Harvard Bioscience Inc Earnings Call

Yahoo | August 9, 2023

Read More 'HBIO' Stories Here

HBIO Price Returns

1-mo -1.86%
3-mo -24.69%
6-mo 0.24%
1-year 80.69%
3-year 40.80%
5-year -19.81%
YTD 51.99%
2022 -60.71%
2021 64.34%
2020 40.66%
2019 -4.09%
2018 -3.64%

Continue Researching HBIO

Want to see what other sources are saying about Harvard Bioscience Inc's financials and stock price? Try the links below:

Harvard Bioscience Inc (HBIO) Stock Price | Nasdaq
Harvard Bioscience Inc (HBIO) Stock Quote, History and News - Yahoo Finance
Harvard Bioscience Inc (HBIO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!